MedTrace Logo

Comparative Analysis of CO2 Monitoring Methods in Patients With CF Undergoing General Anesthesia

NCT03734822 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2019-03-14

Study results available
· View outcomes & findings →

Summary

Four methods are routinely used to monitor CO2 in patients. End tidal CO2 (EtCO2) is monitored through the endotracheal tube during general anesthesia. CO2 is also monitored in other healthcare settings transcutaneously (TCO2), via finger stick capillary CO2 (CapCO2), and arterial blood gas (ABG). The purpose of this study is to perform all four measurements simultaneously during general anesthesia to identify which measure provides the most accurate data with the least amount of patient risk.

Conditions

Interventions

OTHER

End tidal CO2 (EtCO2)

End tidal CO2 (EtCO2) is monitored through the endotracheal tube during general anesthesia.

DEVICE

Transcutaneous CO2 (TCO2)

Continuous and noninvasive real-time monitoring of transcutaneous CO2.

DIAGNOSTIC_TEST

Capillary CO2 (CapCO2)

Capillary CO2 collected by finger stick and run on the i-STAT handheld blood analyzer.

DIAGNOSTIC_TEST

Arterial blood gas (ABG)

Arterial blood gas collected from the radial artery and run on the i-STAT handheld blood analyzer.

Sponsors & Collaborators

  • Nationwide Children's Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-10
Primary Completion
2017-12-20
Completion
2017-12-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03734822 on ClinicalTrials.gov